Villamor, Orle A.
HRN: 17-92-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFAZOLIN 1GM (VIAL)
01/23/2025
01/23/2025
IV
1g
Single Dose
Removal Of Implant
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes